Surya N. Mohapatra, Ph.D. is former Chairman, President and Chief Executive Officer of Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services. Dr. Mohapatra is among a select group of India-born Fortune 500 Chief Executives and has held senior leadership positions in the health care industry for more than 30 years. He has been a strong advocate of patient empowerment and accountability to improve healthcare and reduce costs. Dr. Mohapatra joined Quest Diagnostics in February, 1999 as SVP and COO. He was appointed President in June of 1999 and was elected to the company's Board of Directors in October 2002. In May 2004, he was appointed CEO and was named Chairman of the Board of Directors in December of that year. He is a member of the Board of Directors of XYLEM Inc. and a Trustee of Rockefeller University. In addition, Dr. Mohapatra was a member of the Center for Strategic International Studies Commission on Smart Global Health Policy and has participated in the World Economic Forum, Davos, on healthcare topics. Prior to joining Quest Diagnostics, he served as SVP and a member of the executive committee of GEC-Picker International, now part of Phillips Medical Systems, where he played an important role in the design, manufacture and commercialization of Magnetic Resonance Imaging. Dr. Mohapatra holds a BS in Electrical Engineering from Regional Engineering College (now the National Institute of Technology), Rourkela, India and Sambalpur University, India; a Master of Science in Medical Electronics, University of Salford, England; and a Doctorate in Medical Physics from University of London and the Royal College of Surgeons of England. He is the author of several publications and patents, including the book "Non Invasive Cardiovascular Monitoring by Electrical Impedance Technique." Areas of interest: non-invasive patient monitoring, diagnostic imaging, diagnostic testing, global health and information technology.